Interaction between serum inflammatory cytokines and brain-derived neurotrophic factor in cognitive function among first-episode schizophrenia patients

doi:10.5498/wjp.v14.i12.1804

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (310)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

HTML

216

Tables (1-4)

Sum=268

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=26

Dec 19, 2024 (publication date) through Dec 12, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Psychiatry. Dec 19, 2024; 14(12): 1804-1814
Published online Dec 19, 2024. doi: 10.5498/wjp.v14.i12.1804

Table 2 Correlation analysis between serum brain derived neurotrophic factor levels and inflammatory cytokines and brain derived neurotrophic factor in the schizophrenia group (n = 84)

Serum inflammatory factors	BDNF
Serum inflammatory factors	r value	P value
IL-1β	-0.160	0.145
IL-4	0.196	0.073
IL-6	-0.324^a	0.003
IL-10	0.080	0.470

^aP < 0.05.

BDNF: Brain derived neurotrophic factor; IL: Interleukin.

Citation: Cui LJ, Cai LL, Na WQ, Jia RL, Zhu JL, Pan X. Interaction between serum inflammatory cytokines and brain-derived neurotrophic factor in cognitive function among first-episode schizophrenia patients. World J Psychiatry 2024; 14(12): 1804-1814
URL: https://www.wjgnet.com/2220-3206/full/v14/i12/1804.htm
DOI: https://dx.doi.org/10.5498/wjp.v14.i12.1804